Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jason M Glanz

Showing results (141-150 of 146) with videos related to

Pageof 15
Sort By:
You have reached the last page of results.This site can display upto 146 results.
JAMA|October 26, 2006
Safety of trivalent inactivated influenza vaccine in children 6 to 23 months oldSimon J Hambidge, Jason M Glanz, Eric K France, et al.
JAMA|September 3, 2021
Surveillance for Adverse Events After COVID-19 mRNA VaccinationNicola P Klein, Ned Lewis, Kristin Goddard, et al.
JAMIA Open|June 2, 2022
Development and implementation of a prescription opioid registry across diverse health systemsG Thomas Ray, Andrea Altschuler, Ruchir Karmali, et al.
MMWR. Morbidity and Mortality Weekly Report|July 15, 2021
COVID-19 Vaccination Coverage Among Insured Persons Aged ≥16 Years, by Race/Ethnicity and Other Selected Characteristics - Eight Integrated Health Care Organizations, United States, December 14, 2020-May 15, 2021Cassandra Pingali, Mehreen Meghani, Hilda Razzaghi, et al.
Pediatrics|May 18, 2022
Safety of COVID-19 Vaccination in United States Children Ages 5 to 11 YearsAnne M Hause, David K Shay, Nicola P Klein, et al.
Vaccine|October 25, 2025
Near real-time surveillance and tree-based data mining to assess the safety of respiratory syncytial virus vaccines in older adults in the vaccine safety datalinkJames G Donahue, Noelle M Cocoros, Burney A Kieke, et al.
Pageof 15

Showing results (141-150 of 146) with videos related to

Sort By:
Pageof 15
You have reached the last page of results.This site can display upto 146 results.
JAMA|October 26, 2006
Safety of trivalent inactivated influenza vaccine in children 6 to 23 months oldSimon J Hambidge, Jason M Glanz, Eric K France, et al.
JAMA|September 3, 2021
Surveillance for Adverse Events After COVID-19 mRNA VaccinationNicola P Klein, Ned Lewis, Kristin Goddard, et al.
JAMIA Open|June 2, 2022
Development and implementation of a prescription opioid registry across diverse health systemsG Thomas Ray, Andrea Altschuler, Ruchir Karmali, et al.
MMWR. Morbidity and Mortality Weekly Report|July 15, 2021
COVID-19 Vaccination Coverage Among Insured Persons Aged ≥16 Years, by Race/Ethnicity and Other Selected Characteristics - Eight Integrated Health Care Organizations, United States, December 14, 2020-May 15, 2021Cassandra Pingali, Mehreen Meghani, Hilda Razzaghi, et al.
Pediatrics|May 18, 2022
Safety of COVID-19 Vaccination in United States Children Ages 5 to 11 YearsAnne M Hause, David K Shay, Nicola P Klein, et al.
Vaccine|October 25, 2025
Near real-time surveillance and tree-based data mining to assess the safety of respiratory syncytial virus vaccines in older adults in the vaccine safety datalinkJames G Donahue, Noelle M Cocoros, Burney A Kieke, et al.
Pageof 15